While these findings are highly significant in ameliorating disease pathology in an acute preclinical model, similar peptide-based approaches should be also utilized as a therapeutic strategy for chronic neurodegenerative diseases.
← all excerpts
The status of Nrf2-based therapeutics: current perspectives and future prospects.
1
—
—